Wits RHI
What We Do
Wits RHI is a research and implementation Institute that is dynamic, progressive, and responsive to global and local health emergencies. We pioneer cutting-edge science and innovation in the fields of infectious and vaccine preventable diseases; maternal and family health; antimicrobial resistance, climate change and emerging crises.
Our strength lies in our multi-disciplinary and holistic approach to improving health outcomes at a local and global level through research, technical
assistance, advocacy, policy development, implementation science and health systems strengthening. We identify health problems through sound epidemiological methods and qualitative research, and use a range of analytic and research methods to generate evidence and test and evaluate interventions in a real word setting.
We are a part of the Faculty of Health Sciences at the University of the Witwatersrand, a world-class African University.
We are a Joint United Nations Programme on AIDS (UNAIDS) and South African Medical Research Council (SAMRC) collaborating centre and a strategic partner to the United Nations Population Fund (UNFPA).
Who We Serve
Our work is focused on populations that are most in need, marginalised, or hard to reach. These include:
- Pregnant women and mother-infant pairs
- Women and Men
- Adults and children living with HIV and TB
Wits RHI in Numbers
Leadership
Featured Projects
BIYELA STUDY
The BIYELA Study is a Phase 3 randomized, double-blinded, placebo-controlled trial evaluating the efficacy of the meningococcal serogroup B vaccine rMenB+OMV NZ (Bexsero) in preventing gonococcal infection among individuals born female in South Africa. This study focuses on sexually transmitted infection (STI) prevention, with the primary goal of determining whether the Bexsero vaccine can effectively prevent cervical and/or anorectal gonococcal infections.
View project
IMPAACT 2028
Early treatment of infants living with HIV offers a unique population in which to investigate long-term clinical, immunologic, and virologic outcomes and to better characterize how early ART impacts HIV infection over time. The overarching goals of IMPAACT 2028 are to establish long-term follow-up of participants who received early treatment for future interventional cure and/or remission trials and to establish a unique biorepository from which additional scientific questions can be answered.
View project
CHAMNHA (Climate, Heat, and Maternal and Neonatal Health in Africa)
Investigating the impact of environmental heat exposure around the time of childbirth on women’s and children’s health a community and facility-based qualitative inquiry in Burkina Faso and Kenya.
View project
GSK Neisseria gonorrhoeae GMMA (NgG)
A multi-country Phase 1/2 trial, conducted in an observer-blind, randomized, and placebo-controlled manner, aiming to evaluate the safety and efficacy of the GSK Neisseria gonorrhoeae GMMA (NgG) investigational vaccine in healthy adults aged 18 to 50 (NGG-001).
View project
South African Population Research Infrastructure Network (SAPRIN)
Research in the human and social sciences plays a crucial role in driving social, economic, and cultural development and transformation in South Africa. The overarching goal is to enhance the well-being of poorer South Africans, leading to improved health outcomes and socio-economic advancement. To achieve these aims while reducing government costs, the South African Research Infrastructure Roadmap (SARIR) has been established to guide investments in research infrastructure.
View projectLatest Publications
Pharmacokinetic and clinical associations between doravirine-containing ART and injectable and implantable hormonal contraceptive methods among women living with HIV in South Africa
Abstract
Drug resistance and intolerance of dolutegravir-containing antiretroviral therapy (ART) are rising in low- and middle-income countries, resulting in a potentially increased use of doravirine-containing ART use. There are knowledge gaps regarding doravirine and hormonal contraceptive drug-drug interactions among women living with HIV (WLWH).
Pharmacokinetic and clinical associations between doravirine-containing ART and injectable and implantable hormonal contraceptive methods among women living with HIV in South Africa
Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV
Beyond behavioural change: prioritising structural solutions to control bacterial sexually transmitted infections
Community PrEP delivery for adolescent girls and young women: insights from the DREAMS PrEP Choice Study in Johannesburg, South Africa
Wits RHI in the News
Prof Lee Fairlie leads South Africa’s contribution to the M72/AS01E…
New Global Role for Prof Helen Rees at the International…
Fake and sub-standard drugs are rife globally, but in Africa,…
Our Donors and Partners
Footer
Established in 1994, Wits RHI is part of the Faculty of Health Sciences and the largest research institute of the University of the Witwatersrand.